Taekmin Kwon
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Taekmin Kwon has a total of 63 co-authors. Here are the top co-authors by number of shared publications:
- Sungchan Park
Basic-Clinic Convergence Research Institute, University of Ulsan, Ulsan, Korea
10 shared publications - Kyung Hyun Moon
Department of Urology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea
9 shared publications - Seong Cheol Kim
Basic-Clinic Convergence Research Institute, University of Ulsan, Ulsan, Korea
8 shared publications Kyung Hyun Moon
Department of Urology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea
6 shared publicationsSang Hyeon Cheon
Department of Urology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea
6 shared publicationsSungchan Park
Department of Urology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea
6 shared publications
Latest Publications
- Open Access
- 1 January 2026
- Published by XMLink in The World Journal of Men's Health
- Vol. 44
Dipeptidyl Peptidase-4 Inhibitor Enhances the Efficacy of Docetaxel via Adenosine Triphosphate Depletion and Modulation of Mitochondrial Fusion-Fission in Castration-Resistant Prostate Cancer
Lee WH, et al. World J Mens Health. 2026 ;44:e85. https://doi.org/10.5534/wjmh.260048
- 1 January 2026
- Published by XMLink in The World Journal of Men's Health
- Vol. 44
Open AccessDipeptidyl Peptidase-4 Inhibitor Enhances the Efficacy of Docetaxel via Adenosine Triphosphate Depletion and Modulation of Mitochondrial Fusion-Fission in Castration-Resistant Prostate Cancer
Lee WH, et al. World J Mens Health. 2026 ;44:e85. https://doi.org/10.5534/wjmh.260048
- Open Access
- 9 May 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (19) , e42222
Is it effective to do mathematical analysis for the etiology of nocturia using the nocturia indices derived from the frequency volume chart?: A retrospective observational study
This study aims to determine the problems involved in using a mathematical calculation to analyze the pathophysiology of nocturia using a frequency volume chart (FVC). In this retrospective study, we reviewed 253 patients who completed the FVC during ≥ 3 days for nocturia from January 2017 to February 2019. The etiology of nocturia was defined as a combination of 4 pathophysiologies, including nocturnal polyuria (NP), decreased bladder capacity (dBC), decreased nocturnal bladder capacity, and global polyuria. To analyze the differences according to diagnostic criteria for NP and dBC, 2 definitions were classified. Definition 1: NP is NP index (NPi) > 0.35 and dBC as maximal voided volume (MVV) < 325 mL. Definition 2: NP is NPi = 0.20 to 0.33 depending on age and dBC as MVV < 200 mL. The MVV in the FVC for ≥3 days was significantly higher than that for 1 day (330 mL vs 400 mL, P < .001). During the entire FVC period, all pathophysiology remained unchanged in only 16.6% of cases (inter-day variation). Of 323 days in which nocturia occurred ≥ 2 per night, 118 days (36.5%) full bladder voiding of nocturia was not the same for each day (inter-nocturia variation). According to definitions 1 and 2, the serial changes of NP and dBC showed different patterns. The mathematical calculation used in analyzing the pathophysiology of nocturia using an FVC has problems such as differences according to the duration of FVC and inability to express inter-day and inter-nocturia variations. Therefore, this mathematical calculation is not helpful when determining the treatment modality for nocturia.
- 9 May 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (19) , e42222
Open AccessIs it effective to do mathematical analysis for the etiology of nocturia using the nocturia indices derived from the frequency volume chart?: A retrospective observational study
This study aims to determine the problems involved in using a mathematical calculation to analyze the pathophysiology of nocturia using a frequency volume chart (FVC). In this retrospective study, we reviewed 253 patients who completed the FVC during ≥ 3 days for nocturia from January 2017 to February 2019. The etiology of nocturia was defined as a combination of 4 pathophysiologies, including nocturnal polyuria (NP), decreased bladder capacity (dBC), decreased nocturnal bladder capacity, and global polyuria. To analyze the differences according to diagnostic criteria for NP and dBC, 2 definitions were classified. Definition 1: NP is NP index (NPi) > 0.35 and dBC as maximal voided volume (MVV) < 325 mL. Definition 2: NP is NPi = 0.20 to 0.33 depending on age and dBC as MVV < 200 mL. The MVV in the FVC for ≥3 days was significantly higher than that for 1 day (330 mL vs 400 mL, P < .001). During the entire FVC period, all pathophysiology remained unchanged in only 16.6% of cases (inter-day variation). Of 323 days in which nocturia occurred ≥ 2 per night, 118 days (36.5%) full bladder voiding of nocturia was not the same for each day (inter-nocturia variation). According to definitions 1 and 2, the serial changes of NP and dBC showed different patterns. The mathematical calculation used in analyzing the pathophysiology of nocturia using an FVC has problems such as differences according to the duration of FVC and inability to express inter-day and inter-nocturia variations. Therefore, this mathematical calculation is not helpful when determining the treatment modality for nocturia.
- Open Access
- 8 February 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-8
Diagnosis and clinical significance of prostate calcification using computed tomography
This study aimed to assess the exact location, size, and clinical significance of prostatic calcification using computed tomography (CT). We retrospectively analyzed data from 5,492 patients who underwent CT at the Department of Urology in our hospital between January 2010 and December 2020. After applying exclusion criteria (prostate cancer, post-prostatectomy, indwelling urethral catheter, severe artifacts, and software errors), 4,805 patients were included in the final analysis. Patient age, medical history, laboratory findings, and the International Prostate Symptom Score (IPSS) were collected, with linear regression used to identify predictors of IPSS. Of the 4,805 patients, 1,525 had no calcification, 285 had calcification with a Hounsfield unit (HU) < 100, and 2,995 had calcification with HU ≥ 100. The average age of patients with calcification was significantly higher than that of patients without calcification. Total IPSS scores were significantly elevated in the calcification group, particularly in those with calcifications of HU ≥ 100. The majority of calcifications were located in the central zone (79.3%), followed by the periurethral (48.6%) and transitional zones (42.0%). Only a small number of calcifications were observed in the peripheral zone (0.9%). Multivariate analysis revealed that both age and prostate calcification were significant predictors of urinary symptoms. CT can be effectively utilized to accurately assess the exact location, size, and number of prostate calcifications. Prostate calcification increases with age and is associated with worsened lower urinary tract symptoms.
- 8 February 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-8
Open AccessDiagnosis and clinical significance of prostate calcification using computed tomography
This study aimed to assess the exact location, size, and clinical significance of prostatic calcification using computed tomography (CT). We retrospectively analyzed data from 5,492 patients who underwent CT at the Department of Urology in our hospital between January 2010 and December 2020. After applying exclusion criteria (prostate cancer, post-prostatectomy, indwelling urethral catheter, severe artifacts, and software errors), 4,805 patients were included in the final analysis. Patient age, medical history, laboratory findings, and the International Prostate Symptom Score (IPSS) were collected, with linear regression used to identify predictors of IPSS. Of the 4,805 patients, 1,525 had no calcification, 285 had calcification with a Hounsfield unit (HU) < 100, and 2,995 had calcification with HU ≥ 100. The average age of patients with calcification was significantly higher than that of patients without calcification. Total IPSS scores were significantly elevated in the calcification group, particularly in those with calcifications of HU ≥ 100. The majority of calcifications were located in the central zone (79.3%), followed by the periurethral (48.6%) and transitional zones (42.0%). Only a small number of calcifications were observed in the peripheral zone (0.9%). Multivariate analysis revealed that both age and prostate calcification were significant predictors of urinary symptoms. CT can be effectively utilized to accurately assess the exact location, size, and number of prostate calcifications. Prostate calcification increases with age and is associated with worsened lower urinary tract symptoms.
- Open Access
- 1 January 2025
- Published by XMLink in Investigative and Clinical Urology
- Vol. 66 (6) , 526-533
Descriptive analysis of initial experience with partial nephrectomy and retroperitoneal organ surgery using supine anterior retroperitoneal approach with the da Vinci SP robotic system: Pilot cases
Bae H, et al. Investig Clin Urol. 2025 Nov;66(6):526-533. https://doi.org/10.4111/icu.20250204
- 1 January 2025
- Published by XMLink in Investigative and Clinical Urology
- Vol. 66 (6) , 526-533
Open AccessDescriptive analysis of initial experience with partial nephrectomy and retroperitoneal organ surgery using supine anterior retroperitoneal approach with the da Vinci SP robotic system: Pilot cases
Bae H, et al. Investig Clin Urol. 2025 Nov;66(6):526-533. https://doi.org/10.4111/icu.20250204
- Open Access
- 1 June 2024
- Published by AME Publishing Company in Translational Andrology and Urology
- Vol. 13 (6) , 1004-1013
Comparative study of extraperitoneal singe-port robot-assisted radical prostatectomy and transperitoneal multiport robot-assisted radical prostatectomy using propensity score matching
Background: With the introduction of the da Vinci single-port (SP) robot platform, surgery in a narrow space has become easier, and using this, extraperitoneal radical prostatectomy has been frequently performed recently. However, studies comparing it with existing methods are still lacking. Therefore, in this study, we compared the initial extraperitoneal single-port robot-assisted radical prostatectomy (spRARP) with intraperitoneal multiport robot-assisted radical prostatectomy (mpRARP) and tried to investigate the feasibility of extraperitoneal spRARP. Methods: We retrospectively analyzed patients who underwent RARP performed between January 2019 and April 2023. A total of 184 consecutive patients were enrolled in this study: 64 underwent spRARP and 120 underwent mpRARP. Patient characteristics before and after surgery were investigated, and period of passing gas, foley maintenance period, length of hospital stay, and pain changes were compared and analyzed to estimate post-surgery recovery. To address inherent biases stemming from differing patient characteristics at baseline, we performed an additional analysis after propensity score matching (PSM) (ratio, 1:1). Results: After PSM, both the spRARP and mpRARP groups consisted of 64 patients each. On preoperative examination, there were no significant differences in prostate-specific antigen level, Gleason score (GS), prostate volume, magnetic resonance imaging T stage, or Prostate Imaging-Reporting and Data System score between the two groups. Following surgery, there were no significant differences in operative and console time between the two groups. Notably, the estimated blood loss was considerably lesser in the spRARP group than in the mpRARP group (P=0.049). When comparing pathologic outcomes, the GS, T stage, positive surgical margin, extracapsular extension, and seminal vesicle invasion rates showed no significant differences between the two groups. Four patients who underwent spRARP and six who underwent mpRARP suffered Clavien-Dindo classification grade 3 and 4 complications. After 3 months, there were no significant differences in incontinence or potency between the two groups. However, even after PSM, the period of passing gas was earlier in the spRARP group than in the mpRARP group. Conclusions: In this study, both the extraperitoneal spRARP and transperitoneal mpRARP groups exhibited similar complication rates and surgical outcomes. Furthermore, the spRARP group had a short surgical time and demonstrated early recovery. Therefore, extraperitoneal spRARP is a feasible procedure that is expected to become increasingly popular in the future.
- 1 June 2024
- Published by AME Publishing Company in Translational Andrology and Urology
- Vol. 13 (6) , 1004-1013
Open AccessComparative study of extraperitoneal singe-port robot-assisted radical prostatectomy and transperitoneal multiport robot-assisted radical prostatectomy using propensity score matching
Background: With the introduction of the da Vinci single-port (SP) robot platform, surgery in a narrow space has become easier, and using this, extraperitoneal radical prostatectomy has been frequently performed recently. However, studies comparing it with existing methods are still lacking. Therefore, in this study, we compared the initial extraperitoneal single-port robot-assisted radical prostatectomy (spRARP) with intraperitoneal multiport robot-assisted radical prostatectomy (mpRARP) and tried to investigate the feasibility of extraperitoneal spRARP. Methods: We retrospectively analyzed patients who underwent RARP performed between January 2019 and April 2023. A total of 184 consecutive patients were enrolled in this study: 64 underwent spRARP and 120 underwent mpRARP. Patient characteristics before and after surgery were investigated, and period of passing gas, foley maintenance period, length of hospital stay, and pain changes were compared and analyzed to estimate post-surgery recovery. To address inherent biases stemming from differing patient characteristics at baseline, we performed an additional analysis after propensity score matching (PSM) (ratio, 1:1). Results: After PSM, both the spRARP and mpRARP groups consisted of 64 patients each. On preoperative examination, there were no significant differences in prostate-specific antigen level, Gleason score (GS), prostate volume, magnetic resonance imaging T stage, or Prostate Imaging-Reporting and Data System score between the two groups. Following surgery, there were no significant differences in operative and console time between the two groups. Notably, the estimated blood loss was considerably lesser in the spRARP group than in the mpRARP group (P=0.049). When comparing pathologic outcomes, the GS, T stage, positive surgical margin, extracapsular extension, and seminal vesicle invasion rates showed no significant differences between the two groups. Four patients who underwent spRARP and six who underwent mpRARP suffered Clavien-Dindo classification grade 3 and 4 complications. After 3 months, there were no significant differences in incontinence or potency between the two groups. However, even after PSM, the period of passing gas was earlier in the spRARP group than in the mpRARP group. Conclusions: In this study, both the extraperitoneal spRARP and transperitoneal mpRARP groups exhibited similar complication rates and surgical outcomes. Furthermore, the spRARP group had a short surgical time and demonstrated early recovery. Therefore, extraperitoneal spRARP is a feasible procedure that is expected to become increasingly popular in the future.
- Open Access
- 1 January 2024
- Published by XMLink in Investigative and Clinical Urology
- Vol. 65 (2) , 124-131
Analysis of trend in the role of national and regional hubs in prostatectomy after prostate cancer diagnosis in the past 5 years: A nationwide population-based study
Kim SC, et al. Investig Clin Urol. 2024 Mar;65(2):124-131. https://doi.org/10.4111/icu.20230333
- 1 January 2024
- Published by XMLink in Investigative and Clinical Urology
- Vol. 65 (2) , 124-131
Open AccessAnalysis of trend in the role of national and regional hubs in prostatectomy after prostate cancer diagnosis in the past 5 years: A nationwide population-based study
Kim SC, et al. Investig Clin Urol. 2024 Mar;65(2):124-131. https://doi.org/10.4111/icu.20230333
- Open Access
- 1 January 2023
- Published by XMLink in The World Journal of Men's Health
- Vol. 41 (3) , 649-658
Docetaxel Enhances Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand-Mediated Apoptosis in Prostate Cancer Cells via Epigenetic Gene Regulation by Enhancer of Zeste Homolog 2
Lee WH, et al. World J Mens Health. 2023 Jan;41:e2. https://doi.org/10.5534/wjmh.220073
- 1 January 2023
- Published by XMLink in The World Journal of Men's Health
- Vol. 41 (3) , 649-658
Open AccessDocetaxel Enhances Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand-Mediated Apoptosis in Prostate Cancer Cells via Epigenetic Gene Regulation by Enhancer of Zeste Homolog 2
Lee WH, et al. World J Mens Health. 2023 Jan;41:e2. https://doi.org/10.5534/wjmh.220073
- Open Access
- 28 October 2022
- Published by Wolters Kluwer Health in Medicine
- Vol. 101 (43) , e31295
Analysis of changes in the pathophysiology of nocturia according to the number of nocturia episode, age, and gender using frequency volume charts: A retrospective observational study
Purpose: To evaluate the pathophysiology of nocturia based on the frequency volume chart, and determine the risk factors for nocturia occurring ≥2 times per night. Materials and methods: In this retrospective study, we reviewed 311 patients with complaints of nocturia from January 2017 to February 2019 at our institution. Nocturnal polyuria (NP) and global polyuria (GP) were defined as NP index >0.35 regardless of age and 24 h urine volume >2.5 L/day, respectively. Decreased bladder capacity (dBC) was when the maximal voided volume was 0. Results: In total, 273 patients were included in the primary analyses. Of 802 days from 273 frequency volume charts, the median number of nocturia was 1 episode per day. Further, NP (odds ratios [OR] 7.01), GP (OR 4.25), dBC (OR 3.00), dNBC (OR 10.12), and age (OR 1.04) had the association with nocturia ≥2 times per night. There was a significant stepwise increase in NP, dNBC, dBC, and GP with the number of nocturia episodes. As patient age increased, the likelihood of NP (P < 0.001) and dBC (P < 0.001) being the cause for nocturia tended to increase, but that of dNBC (P = 0.022) and nocturia without cause (P = 0.007) tended to decrease. Moreover, dBC was more likely to cause nocturia in female patients than in male patients (P < 0.001). Conclusion: NP, dBC, dNBC, and GP are important factors involved in the pathophysiology of nocturia occurring ≥2 times per night.
- 28 October 2022
- Published by Wolters Kluwer Health in Medicine
- Vol. 101 (43) , e31295
Open AccessAnalysis of changes in the pathophysiology of nocturia according to the number of nocturia episode, age, and gender using frequency volume charts: A retrospective observational study
Purpose: To evaluate the pathophysiology of nocturia based on the frequency volume chart, and determine the risk factors for nocturia occurring ≥2 times per night. Materials and methods: In this retrospective study, we reviewed 311 patients with complaints of nocturia from January 2017 to February 2019 at our institution. Nocturnal polyuria (NP) and global polyuria (GP) were defined as NP index >0.35 regardless of age and 24 h urine volume >2.5 L/day, respectively. Decreased bladder capacity (dBC) was when the maximal voided volume was 0. Results: In total, 273 patients were included in the primary analyses. Of 802 days from 273 frequency volume charts, the median number of nocturia was 1 episode per day. Further, NP (odds ratios [OR] 7.01), GP (OR 4.25), dBC (OR 3.00), dNBC (OR 10.12), and age (OR 1.04) had the association with nocturia ≥2 times per night. There was a significant stepwise increase in NP, dNBC, dBC, and GP with the number of nocturia episodes. As patient age increased, the likelihood of NP (P < 0.001) and dBC (P < 0.001) being the cause for nocturia tended to increase, but that of dNBC (P = 0.022) and nocturia without cause (P = 0.007) tended to decrease. Moreover, dBC was more likely to cause nocturia in female patients than in male patients (P < 0.001). Conclusion: NP, dBC, dNBC, and GP are important factors involved in the pathophysiology of nocturia occurring ≥2 times per night.
- 27 May 2022
- Published by Springer Nature in World Journal of Urology
- Vol. 40 (7) , 1845-1851
Effects of metabolic syndrome on renal stone progression
Purpose Studies on howmetabolic syndrome affects renal stone progression in untreated asymptomatic patients are lacking. Therefore, we investigated the effect of metabolic syndrome on changes in renal stone size. Materials and methods We retrospectively analyzed 820 patients with renal stones incidentally detected on CT during regular health examinations and who underwent follow-up CT evaluations for > 1 year. The patients were divided into two groups according to the presence of metabolic syndrome. Changes in stone size during the follow-up were assessed, and differences were compared according to various factors. Predictors of stone size change on CT were assessed using linear regression analysis. Results Overall, 820 asymptomatic patients without a history of stone treatments and with a mean follow-up of 52.4 months were included. Of these, 104 (12.7%) had metabolic syndrome and 335 (40.9%) showed stone size increase during the follow-up. The stone size at diagnosis was not significantly different between patients with and without metabolic syndrome (225.3 ± 332.6 vs. 183.9 ± 310.2 mm3, p = 0.159); however, a significant difference was observed in the change in stone size at follow-up (148.5 ± 352.0 vs. 81.5 ± 222.4 mm3, p = 0.001). Multivariable analysis showed that age (β = − 0.11; − 5.92 to −0.69; p = 0.013), fasting glucose level ≥ 100 mg/dl (β = 0.11; 9.78–99.73; p = 0.017), and metabolic syndrome (β = 0.10; 9.78–99.73; p = 0.017) were factors predictive of stone size changes. Conclusion Metabolic syndrome, fasting glucose level ≥ 100 mg/dl and young age are positively related to renal stone size changes. Therefore, periodic follow-up and metabolic syndrome management are required in asymptomatic patients with renal stones, especially in young age.
- 27 May 2022
- Published by Springer Nature in World Journal of Urology
- Vol. 40 (7) , 1845-1851
Effects of metabolic syndrome on renal stone progression
Purpose Studies on howmetabolic syndrome affects renal stone progression in untreated asymptomatic patients are lacking. Therefore, we investigated the effect of metabolic syndrome on changes in renal stone size. Materials and methods We retrospectively analyzed 820 patients with renal stones incidentally detected on CT during regular health examinations and who underwent follow-up CT evaluations for > 1 year. The patients were divided into two groups according to the presence of metabolic syndrome. Changes in stone size during the follow-up were assessed, and differences were compared according to various factors. Predictors of stone size change on CT were assessed using linear regression analysis. Results Overall, 820 asymptomatic patients without a history of stone treatments and with a mean follow-up of 52.4 months were included. Of these, 104 (12.7%) had metabolic syndrome and 335 (40.9%) showed stone size increase during the follow-up. The stone size at diagnosis was not significantly different between patients with and without metabolic syndrome (225.3 ± 332.6 vs. 183.9 ± 310.2 mm3, p = 0.159); however, a significant difference was observed in the change in stone size at follow-up (148.5 ± 352.0 vs. 81.5 ± 222.4 mm3, p = 0.001). Multivariable analysis showed that age (β = − 0.11; − 5.92 to −0.69; p = 0.013), fasting glucose level ≥ 100 mg/dl (β = 0.11; 9.78–99.73; p = 0.017), and metabolic syndrome (β = 0.10; 9.78–99.73; p = 0.017) were factors predictive of stone size changes. Conclusion Metabolic syndrome, fasting glucose level ≥ 100 mg/dl and young age are positively related to renal stone size changes. Therefore, periodic follow-up and metabolic syndrome management are required in asymptomatic patients with renal stones, especially in young age.
- 12 May 2021
- Published by S. Karger AG in Urologia Internationalis
- Vol. 105 (7-8) , 680-686
Varying Outcomes among Patients with Large Angiomyolipomas according to the Treatment Method
Purpose: This study aimed to evaluate the outcomes of large angiomyolipoma (AML) treatment by selective arterial embolization (SAE) versus nephron-sparing surgery (NSS) using a robotic surgical system. Materials and Methods: Between January 2011 and June 2018, we retrospectively reviewed 25 patients who underwent robot-assisted partial nephrectomy (RAPN) or SAE for large AMLs. Ten patients underwent RAPN, and 15 underwent SAE. Patient demographics, AML characteristics, and operative and postoperative clinical outcomes were recorded and analyzed. Outcomes were compared between patients who underwent RAPN and patients who underwent SAE. Specifically, changes in renal function and size were evaluated after the treatment. Results: The mean age of the patients was 52.9 years, and 22 of 25 patients were female. The mean maximum AML diameter on computed tomography was 8.9 cm, and 8 patients had multiple masses. Twenty-two of 25 patients had moderate to high RENAL complexity. Patients who underwent SAE had more symptoms (p = 0.018) and higher RENAL complexity scores (p = 0.013) on average. On average, tumor size decreased by 99% among RAPN patients and by 58% among SAE patients (p = 0.001). Although the mean pretreatment estimated glomerular filtration rate (eGFR) was higher among RAPN patients (99.8 vs. 80.0 mL/min/1.73 m2, p = 0.043), there were no significant changes in eGFR in either group after the treatment. One patient in the RAPN group experienced complications, but the postoperative ileus resolved without intervention. Conclusions: Both RAPN and SAE were effective and feasible treatment options for large AMLs. The AML characteristics and the condition of the patient might be important in determining the appropriate treatment method.
- 12 May 2021
- Published by S. Karger AG in Urologia Internationalis
- Vol. 105 (7-8) , 680-686
Varying Outcomes among Patients with Large Angiomyolipomas according to the Treatment Method
Purpose: This study aimed to evaluate the outcomes of large angiomyolipoma (AML) treatment by selective arterial embolization (SAE) versus nephron-sparing surgery (NSS) using a robotic surgical system. Materials and Methods: Between January 2011 and June 2018, we retrospectively reviewed 25 patients who underwent robot-assisted partial nephrectomy (RAPN) or SAE for large AMLs. Ten patients underwent RAPN, and 15 underwent SAE. Patient demographics, AML characteristics, and operative and postoperative clinical outcomes were recorded and analyzed. Outcomes were compared between patients who underwent RAPN and patients who underwent SAE. Specifically, changes in renal function and size were evaluated after the treatment. Results: The mean age of the patients was 52.9 years, and 22 of 25 patients were female. The mean maximum AML diameter on computed tomography was 8.9 cm, and 8 patients had multiple masses. Twenty-two of 25 patients had moderate to high RENAL complexity. Patients who underwent SAE had more symptoms (p = 0.018) and higher RENAL complexity scores (p = 0.013) on average. On average, tumor size decreased by 99% among RAPN patients and by 58% among SAE patients (p = 0.001). Although the mean pretreatment estimated glomerular filtration rate (eGFR) was higher among RAPN patients (99.8 vs. 80.0 mL/min/1.73 m2, p = 0.043), there were no significant changes in eGFR in either group after the treatment. One patient in the RAPN group experienced complications, but the postoperative ileus resolved without intervention. Conclusions: Both RAPN and SAE were effective and feasible treatment options for large AMLs. The AML characteristics and the condition of the patient might be important in determining the appropriate treatment method.